Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of “Hold” from Brokerages

Health Catalyst, Inc. (NASDAQ:HCAT) has earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $4.3182.

A number of equities research analysts recently commented on the stock. William Blair reissued an “outperform” rating on shares of Health Catalyst in a research report on Tuesday, November 11th. Stifel Nicolaus decreased their price objective on Health Catalyst from $4.50 to $3.75 and set a “hold” rating for the company in a report on Tuesday, November 11th. Wells Fargo & Company dropped their target price on Health Catalyst from $6.00 to $5.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 11th. Citigroup decreased their price target on Health Catalyst from $3.25 to $2.75 and set a “neutral” rating for the company in a research note on Friday, January 9th. Finally, UBS Group reissued an “outperform” rating on shares of Health Catalyst in a report on Tuesday, November 11th.

Health Catalyst Stock Down 6.0%

NASDAQ:HCAT opened at $1.73 on Wednesday. The company’s 50-day simple moving average is $2.28 and its 200-day simple moving average is $2.74. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.88 and a current ratio of 1.88. Health Catalyst has a fifty-two week low of $1.72 and a fifty-two week high of $5.56. The stock has a market capitalization of $122.36 million, a P/E ratio of -1.09 and a beta of 1.73.

Insider Buying and Selling

In other news, General Counsel Benjamin Landry sold 27,425 shares of Health Catalyst stock in a transaction on Friday, December 5th. The shares were sold at an average price of $2.64, for a total transaction of $72,402.00. Following the completion of the sale, the general counsel directly owned 100,000 shares in the company, valued at approximately $264,000. The trade was a 21.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Julie Larson-Green sold 47,997 shares of the company’s stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $2.67, for a total value of $128,151.99. Following the completion of the transaction, the director directly owned 73,573 shares in the company, valued at approximately $196,439.91. The trade was a 39.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.60% of the stock is owned by company insiders.

Institutional Trading of Health Catalyst

Several large investors have recently added to or reduced their stakes in the company. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Health Catalyst in the third quarter valued at about $39,000. Cresset Asset Management LLC purchased a new stake in Health Catalyst in the second quarter valued at approximately $39,000. Divergent Planning LLC acquired a new position in Health Catalyst in the 2nd quarter worth approximately $45,000. FNY Investment Advisers LLC purchased a new position in Health Catalyst during the 3rd quarter worth approximately $45,000. Finally, Focus Partners Wealth acquired a new stake in Health Catalyst during the 1st quarter valued at approximately $46,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.